| scholarly article | Q13442814 |
| P50 | author | Cornelia Lass-Florl | Q87722456 |
| P2860 | cites work | Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial) | Q28298468 |
| Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
| Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group | Q33854646 | ||
| Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model | Q33981712 | ||
| Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study | Q33983629 | ||
| Voriconazole: a new triazole antifungal agent | Q35069136 | ||
| Liposomal amphotericin B: clinical experience and perspectives | Q36140647 | ||
| Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed? | Q40500906 | ||
| A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group | Q40612309 | ||
| Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy | Q45172488 | ||
| An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. | Q53349495 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| amphotericin B | Q412223 | ||
| invasive aspergillosis | Q3625278 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 929-932 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Standard dosing regimen of liposomal amphotericin B is as effective as a high-loading dose for patients with invasive aspergillosis: AmBiLoad trial | |
| P478 | volume | 5 |
Search more.